FDA Action Update, August 2026: Approvals, Clearances, and DesignationsByIsabella Ciccone, MPHSeptember 3rd 2026
FDA Action Update, Week of August 23, 2026: Authorization, Clinical Hold, and ClearanceByIsabella Ciccone, MPHAugust 30th 2026
Clinical Impacts of New FDA-Approved Oveporexton for Narcolepsy Type 1: Sara Sarkey, PhDBySara Sarkey, PhDAugust 28th 2026
Solriamfetol Improves Wakefulness and Sleepiness in Chinese Patients With Obstructive Sleep ApneaByMarco MeglioAugust 17th 2026
Favorable Phase 1 Data for Orexin-2 Agonist BP-205, Broader Pipeline Progress Headline Harmony’s Q2 UpdateByLouie PasculliAugust 6th 2026